INTRODUCTION
Prescription and renewal of patient drugs are among the most commonly used treatments in primary care. 1 The prescription process is a major concern for public health policies and efforts are required to promote the continuous improvement of optimal and adequate prescription in primary healthcare. Studies have shown that errors related to drug prescription are common and avoidable 2 ; they are also the cause of a high level of morbidity and mortality recorded among populations. [3] [4] [5] Taking into account the increased complexity of health conditions caused by an aging population and multi-morbidity, patients' exposure to iatrogenic damage caused by drug misuse and interactions is likely to grow in proportion to these changes. It is therefore essential to improve the quality and safety of prescribing, as well as optimize the use of medicines, making it a priority for current health policies. 2 In this context, the computerization of prescriptions based on modern information and communication technologies (ICT) is supported in many developed countries. 6 Electronic prescription (e-prescribing) is intended to be an inter-operational platform which facilitates the exchange of patients' drug therapy information between health professionals and organizations in primary care and community pharmacies. 7 E-prescribing can improve the drug prescription process by responding to specific user needs as well as reducing inconsistencies. 2 E-prescribing is a promising technology that has the potential to improve the quality of drug use especially in ambulatory and primary care, where treatments for chronic diseases are used for extended periods. 8 Motulsky et al 9 indicate that stakeholders in many countries have made considerable efforts in order to promote the widespread use of e-prescribing by health professionals. However, despite major investments and widespread availability of e-prescribing systems, health providers do not always make use of this technology for prescribing and renewal of treatments. [10] [11] [12] [13] Cresswell et al 2 assert that e-prescribing management computer systems implemented in medical clinics vary considerably in terms of functionality, level of interoperability, cost, and involvement of stakeholders in the strategic choices related to the implementation of these technologies. Problems such as a predetermined deficit in norms governing the attribution of public contracts, a lack of functional specifications for choices that stakeholders have adopted, and a lack of harmonization in the systems implementation strategies may also accentuate the degree of implementation of e-prescribing. 14 15 As main users of e-prescribing systems, healthcare professionals are best positioned to identify the barriers and facilitators they face in their work environment that could affect the success of these systems. However, most studies related to e-prescribing implementation in primary care are fairly recent and few have addressed end-users' perceptions of barriers and facilitators in the implementation process. 7 Considering users' perceptions of barriers and facilitators to the implementation of e-prescribing systems could help reveal which implementation strategy could be successful.
In order to expose these barriers and facilitators, we conducted an exploratory systematic review on the implementation of e-prescribing in the daily work setting of primary healthcare providers. This review sought to answer this question: What are users' perceptions of barriers and facilitators to e-prescribing implementation in primary care?
METHODS

Search strategy
An information specialist developed the literature search strategy from the research question. We searched PubMed to identify applicable articles published within a period of 10 years (from January 1, 2002 to December 11, 2012) , in order to focus on more contemporary systems. See online supplementary appendix 1 for search parameters used.
Selection criteria
We included studies with an empirical design, either qualitative, quantitative, or mixed-methods. These studies should present a clearly stated data collection process as well as research methods and measurement tools used. As such, editorials, comments, position papers, and unstructured observations were excluded from this review.
Included studies focused on the users' experience of eprescribing implementation. User groups considered included: physicians, clinical staff (including nurses), pharmacists, pharmacy staff, and others ( patients, IT staff, and managers). We included studies that took place in primary care (including ambulatory or community healthcare settings). However, studies involving secondary and tertiary care levels could also be included, as long as there was a linkage of the e-prescribing system with primary care settings.
Also, studies had to provide data on barriers and facilitators to e-prescribing implementation in their results or discussion sections to be included. These barriers or facilitators had to be based on empirical evidence.
If a study was reported in more than one publication and presented the same data, we only included the most recent publication. However, if new data were presented in multiple publications describing the same study, all were included. Publications were not excluded based on language used.
Screening, data extraction, and presentation
Two authors (ENS and SG) independently reviewed all titles and abstracts and reached consensus on included studies. A third author (MPG) confirmed included and excluded studies. Full text review of the selected studies was done by three authors ( JPG, ENS, and SG).
We used a validated data extraction grid from previous research on the classification of barriers and facilitators to ICT implementation in healthcare settings. 16 The data extraction grid developed used both inductive and deductive methods, following established theoretical concepts, [17] [18] [19] particularly the technology acceptance model 20 and the diffusion of innovations theory. 21 We developed the data extraction grid in Microsoft Excel 2010. We took all included publications, and three reviewers (ENS, JPG, and SG) independently read and identified sections of the publications that presented a relevant barrier or facilitator to the implementation of e-prescribing from the users' perspective. ENS and JPG coded these selected sections in the program. We also extracted data regarding: year of publication, country, study design (quantitative, qualitative, or mixed-methods), theoretical framework ( present or absent), type of participants, care setting, technology used, objectives of the study, data collection methods, and main findings.
We used the logical model of healthcare quality proposed by Donabedian, coupled to the themes proposed by Barber et al, 22 as the analytical framework for summarizing our findings. 23 24 We transposed extracted data into this framework using thematic analysis. This framework highlights e-prescribing users' perceptions under the dimensions of system functionality, human perspectives, and organizational factors defined by Barber et al, 22 23 which are classified according to the structure, process, and outcomes categories from the Donabedian's model, thus providing a 3×3 thematic classification matrix.
Study quality assessment
We used the mixed methods appraisal tool (MMAT)-a scoring system which presents evaluation criteria for quantitative, qualitative, and mixed-methods studies-proposed by Pluye et al, 25 for appraising the quality of included studies. Two authors (ENS and JPG) independently screened each study and gave it a quality score. No studies were excluded based on their scores (results for quality assessment available on request).
RESULTS
Included studies
In total, we identified 230 references from bibliographic databases, of which we retained 44 publications for full-text review. After applying the inclusion criteria, we excluded 10 of these publications: four were not about e-prescribing, two did not mention barriers or facilitators, two did not possess an empirical design, and two did not concern primary care. The review therefore included 34 publications, 1 7 9 12 13 26-54 corresponding to 28 individual studies, because paired publications by Abramson, 28 34 Crosson, 30 50 Grossman, 7 33 Lapane and Goldman, 38 42 Weingart, 44 47 and Tamblyn 49 53 were considered as one study. The number of studies included at various stages of the review process is described in a study selection flow diagram (figure 1).
Characteristics of included studies
The characteristics of included studies are summarized in online supplementary appendix 2. The most frequent types of technology covered were: e-prescribing system (n=20 studies), 9 13 26 27 29-32 35 38-44 46-51 53 54 electronic health records (EHR) with e-prescribing system (n=4), 28 34 37 45 52 both of these systems (n=3), 1 7 12 33 and the personal digital assistant (PDA) 36 with prescribing software and drug information. Computerized physician (or prescription, or provider) order entry systems (CPOE) were considered in the search, but not included since they are traditionally used in secondary and tertiary care and are confined within hospital settings, [55] [56] [57] [58] which are not the focus of this review.
The majority of studies took place in North America (n=22, 78.6%). Of those, 20 are from the USA 40 43 45 and the UK (n=2). 32 52 We also included one study from Singapore. 46 All studies were published since 2005 and more than half of the included articles were published since 2010 (n=20, 58.8%).
Twelve studies (42.9%) exclusively involved physicians, 1 12 13 27 28 34 36 37 43-45 47 49 53 54 while another two studies targeted exclusively pharmacists (7.1%). 35 40 Six studies included physicians and their staff (21.4%), 30 31 38 39 41 42 50 52 three studies involved pharmacists and their staff (10.7%), 26 32 48 and five studies (17.9%) include more than one of these groups and/or other types of users. Twelve of the studies (42.9%) were quantitative, primarily using surveys. 13 
Results presentation
We grouped factors representing barriers and facilitators to e-prescribing implementation into the nine broad themes of the analytical framework. Each theme is divided into factors representing the content extracted from the publications (explanation for each term used can be found in figure 2 ). Nearly all factors were perceived both as a facilitator and as a barrier, depending on the context. It is worthwhile to mention that overall more facilitators (332) than barriers (264) were mentioned. The majority of factors were common to all user groups. A summary of extracted data is presented in table 1 (see online supplementary appendix 3 for full classification). Results regarding each of the nine themes from our analytical framework are presented below.
System functions Structure
Design and technical concern aspects of e-prescribing implementation was the most frequently mentioned factor, extracted 82 times over the 90 elements of that theme. This factor was mostly considered as a barrier to e-prescribing implementation by all user groups. The most frequently mentioned barriers were the limitations related to software or hardware, and system problems (ie, prescriber had to manually replace data, complexity of the commercial system, or inadequacies of current e-prescribing product). Generally, inadequate interfacing with other IT systems was considered as a barrier by users and was mainly related to the uncertainty about which local pharmacies accept electronic prescriptions. Content appropriate for the user (27) was perceived as a barrier when prescribing history was not updated, 31 33 and did not present clinically relevant data allowing an overview of patient adherence to their prescriptions. 33 49 51 An overwhelming number of different forms and strand medications available in a search query or a low level of confidence in formularies were also mentioned as barriers. 1 7 26 42 52 Otherwise, the possibility to have an overview of patient drugs, 33 45 47 a follow-up of patient adherence to their prescriptions, 42 as well as access to lab results 51 were mentioned as facilitators to e-prescribing implementation. Moreover, reminders for patient with chronic disease 52 and electronic medication renewal 38 47 were appreciated by physicians.
Alerts (17) were reported as barriers due to their frequency and their lack of relevance, 27 28 39 47 51 52 but were considered useful when prescribing an unfamiliar medication to avoid harmful interactions, to look something up in a drug or medical reference, or to change the way they monitored a patient. 28 34 44 46 47 51 Lack of generic substitution options (5) or lack of its flexible options was also reported as a barrier. 9 27 33 53 Outcome Overall, the perception that e-prescribing would improve patient security (21 elements) was a facilitator to its implementation. 7 
Human perspective Structure
Agreement with e-prescribing was the most cited factor of this theme (31 elements). Resistance to change was observed among physicians, particularly when they did not see an added value of e-prescribing 9 13 36 or when they perceived inadequate decision support. 49 52 Also, they did not want to solve implementation problems and believed this should be done by clinical staff. 41 50 51 Practice using both prescribing systems (traditional and electronic) at the same time generally discontinued the implementation process of e-prescribing until the expected final adoption. 1 7 50 51 However, physicians and pharmacists who were voluntarily enrolled in the program had more favorable opinions and positive attitudes about the technology. 7 30 37 45-47 50 53 54 Clinical staff considering the e-prescribing benefits welcomed the opportunity to expand their job responsibilities. 1 39 51 Pharmacy owners were resistant to e-prescribing implementation when it involved a top down decision from pharmacy chains and preferred to trust their Table 1 Users' perception in relation to the principal factors raised in the studies own systems regarding prescriber and practice contact information. 1 9 Factors specific to the e-prescribing structure also included perceived usefulness (12), 33 patients' attitudes and preferences towards e-prescribing (7), 7 37 43 44 47 51 54 and self-efficacy (belief in one's competence to use the e-prescribing) (4), 38 39 46 standing for half of the elements of this theme.
We found eight other factors related to human perspective linked to the structure (representing a total of 38 elements), but these were less cited in the studies (eg, socio-demographic characteristics like age, gender, and experience, and support and promotion of e-prescribing by colleagues).
Process
Productivity (efficiency) represented 25 of the 45 elements for that theme and was perceived more frequently as a facilitator 7 The other factors were patient/clinician interaction (6), 29 38 39 41 42 54 autonomy (4), 1 51 perceptions of other professionals' performance (3), 1 9 38 confidence in e-prescribing developer and vendor (3), 42 47 50 impact on clinical uncertainty (2), 7 29 and risk-benefit equation (2). 38 49 Outcomes Time issues represented 16 of the 35 extracted elements for that theme. Physicians and pharmacists have reported gains in time at post-implementation stage, 29 35 37 38 43 45 54 but this was not the case at the pre-implementation or transition phases, where they believe that it was not the best use of their time. 27 41 50 However as an outcome expectancy (8), physicians and clinical staff expected the system to be useful to improve patient care with multiple, complex problems. 35 39 50 Observability (8) 29 37 39 42 46 54 was seen as a facilitator since physicians were able to view the medication traceability compliance of patients. Finally, impact on professional security was also mentioned. 9 43 
Organizational context Structure
The resources factor, including information technology support, training, as well as material and human resources, accounted for 29 of the elements of that theme. 51 54 Factors related to implementation strategiessuch as a strategic plan to implement e-prescribing, the participation of end-users in the implementation, organizational readiness, as well as incentive and innovation structures-stood for 17 of the extracted elements. 27 29 32 39 41 42 50 51 53 54 Characteristics of the health structure factors, referring to setting of care, 35 54 practice size, 12 status, 12 54 physician salary structure, 9 and workforce shortage 9 accounted for seven elements extracted. Staff skills such as the influence of leadership were mentioned three times. Fifteen macro organizational elements were extracted and are mainly related to financial support 29 47 51 and healthcare policies. 
Organizational context Process
Work process was the most important factor of this theme (24 elements). When e-prescribing was integrated, work process was facilitated and workflow was improved. 1 13 33 37-42 53 However, these are reported as barriers in the transition phase.
7 9 13 26 27 32 34 54 The organizational aspect of professional interaction, including team spirit, 39 relation between different health professionals, 7 9 47 48 and collaboration effort 47 50 accounted for 10 of the extracted elements. The other factors in that theme were barriers related to the lack of organizational support to provide a central, up-to-date source of data, drug code, and formularies. 27 30 38 51 54 Outcomes Again, the outcomes at the post-implementation stage were reported as improvements, but were seen as barriers during the implementation process mainly for the time saving factor (23 elements). Time was saved, among others, by reducing staff time spent processing prescriptions 38- 40 42 43 46 47 51 52 and their renewal. 7 53 The pattern of improvement perceived after implementation is observed for cost issues (11) 7 13 27 35 38 43 51 53 54 and change in task (15), 7 9 26-28 37 42 46 48 53 54 including additional tasks, work flexibility, and impact on business practices.
DISCUSSION
With this exploratory systematic review, we wanted to identify users' perception of barriers and facilitators to implementing eprescribing. From the 28 included studies, users' perceptions mostly relate to these factors: design and technical concerns, interoperability, content appropriate for the users (relevance), agreement with e-prescribing (welcoming/resistant), productivity (efficiency), and resources. These factors reveal that users want a functional, accessible, and supported e-prescribing system that responds to their professional needs. 33 34 39 46 51 Also, the implemented system needs to possess features that enable facilitated exchange between organizations, 37 38 but also allows a more coordinated and effective care. 39 Furthermore, the organization should put emphasis on education and training at the pre-implementation stage to ensure a better transition. 46 50 54 Users' perception of productivity is prevalent in terms of facilitators. For 80% of the elements found under that factor, e-prescribing seems to improve productivity, allowing overall accessibility to the medication history as well as improving efficiency and quality of care. The same observation can be made about the availability of resources, where 62% of the elements are perceived as facilitators when users receive good support and training in addition to an adequate access to material resources.
On the other hand, users perceive more barriers than facilitators regarding interoperability (74.4%). Users believe that the time taken to transmit a prescription to the pharmacy can be longer, the compatibility of pharmacists' and physicians' systems can be problematic, the connectivity with EHR is lacking, and they perceive a gap in communication. The unavailability of a way to externally purchase patient treatments that are not available at the pharmacy and the obligation to make a phone call to obtain prior authorization to deliver a treatment afterwards are also seen as important barriers to interoperability. Moreover, design and technical concerns are also perceived more often as barriers (65.9%). The elements that emerge from that are mainly related to updating data, functional disorders of the system, irrelevant alerts, the uncertainty on the real doses to prescribe, and the impossibility to validate a prescription electronically.
Moreover, some factors that can be seen as barriers in the early stages or before the implementation may become facilitators later on in the process of implementation. The opposite is also true. Some barriers that may arise during the first steps of implementation have a solution in the next steps of the process, such as initial transmission problems solved 7 and pharmacies accepting more and more e-prescriptions. 28 Also, time and efficiency can be gained with e-prescribing in the later stages, whereas the opposite is observed during the beginning of implementation. 7 26 28 39 47 On the other hand, some features may seem interesting to the users at first glance but can cause some serious problems when used: errors may arise using default settings, 28 42 and some information may be unreliable, 1 51 inconsistent, 26 33 51 54 or even superfluous. 7 26-28 39 47 51 52 Furthermore, the feature may not work. 7 13 28 Studies on e-prescribing implementation are quite recent. Indeed, the majority of studies were published since 2010. This technology gained interest recently due to its promises for improving patient care in a context of increased healthcare complexification.
11 27 29 33 34 Moreover, one third of the studies include a theoretical framework, which is superior to the 21% reported in a systematic review on EHR implementation by McGinn et al. 59 It is worth mentioning that there is a change in users' perceptions between the different phases of e-prescribing implementation. This is most apparent between the pre-implementation phase, where non-users and future users have a less favorable opinion of e-prescribing, and the transition and postimplementation phases, where the opinion on e-prescribing becomes more favorable with more frequent use of the technology. 13 39 43 45 48 50 51 54 More importantly, attitudes also have an important influence on the adoption of e-prescribing. Indeed, a positive attitude towards e-prescribing contributes to its successful adoption. Conversely, users who believe that e-prescribing has no value are less inclined to use the technology when it is implemented. This attitude can also change during the transition process, depending on the evolution of users' perceptions regarding e-prescribing. 53 The transition process is decisive in the full adoption of e-prescribing by an organization: a negative attitude can potentially lead to the abandonment of the technology, 1 7 9 36 41 50-52 whereas a positive attitude is more likely to lead to a favorable adoption of e-prescribing. 1 7 30 39 45-47 50 53 54 These findings can be addressed using Azjen's theory of planned behavior. 39 60 Even though the importance of health managers and public involvement in innovative technology implementation and diffusion is recognized, their perceptions remain under-studied. [61] [62] [63] In this review, physicians' perceptions were addressed in 75% of included studies (21.4% for clinical staff ), whereas those of pharmacists (and their staff ) appeared in 28.6% of studies.
Perceptions from other user groups (managers, IT staff, and patients) are almost absent from the reviewed literature, accounting for 7% of studies, making it difficult to consider their perspectives, even if they could influence the success of e-prescribing implementation. 54 
Limitations
Our results must be interpreted with some caution due to the limitations of this review. First, we only used one bibliographic database (PubMed) in the literature search. Thus, it is possible that relevant studies published in journals that are not indexed in PubMed are not included, but due to the explorative nature of our review and the percentage of duplicates reported between multiple databases, 64 65 we think that we retrieved most current work related to e-prescribing implementation. Second, since we based the analysis of our findings on a predetermined framework, the use of other theoretical or analytical frameworks could reveal different perspectives. Nonetheless, we deem that the chosen framework answers adequately the question of our systematic review and provides a logical and useful model of factors affecting e-prescribing implementation. Finally, the findings that are presented only relate to the content that has been published. We did not contact authors of included studies for supplementary information. We think that the editing policies applied in the scientific press ensure that we had access to sufficient content to meet our objectives. In the end, we were able to conduct this exploratory review following the standards of mixed-methods systematic reviews. 25 
CONCLUSION
The findings reported in this review provide evidence that design and technical concerns, interoperability, relevance of the data, attitude towards e-prescribing, productivity, and available resources are important factors to the implementation of e-prescribing for the users. Implementation strategies should focus on these factors in order to facilitate the adoption of this technology. It is interesting to note that some factors can be perceived as barriers or as facilitators depending on the implementation phase of e-prescribing, and can change in nature (changing to a barrier or a facilitator) during the process of implementation. Moreover, attitudes users and future users have in relation to e-prescribing and its implementation may have an influence on the success of the adoption of the technology. Finally, future studies should put the emphasis on the perceptions of other user groups, such as pharmacists, managers, vendors, and patients, whose perspectives remain overlooked in the literature.
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